Brief: Lyell Immunopharma Q3 Net Income USD -44.583 Million
07/11/2024 21:06
Nov 07 (Reuters) - Lyell Immunopharma Q3 revenue USD 34 thousand. * Q3 operating expenses USD 50.539 million * Q3 adjusted net income USD -37.064 million * Q3 operating income USD -50.505 million
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma